Analyzing NeurAxis (NASDAQ:NRXS) and Getinge AB (publ) (OTCMKTS:GNGBY)

Risk & Volatility

NeurAxis has a beta of 4.27, indicating that its stock price is 327% more volatile than the S&P 500. Comparatively, Getinge AB (publ) has a beta of 0.84, indicating that its stock price is 16% less volatile than the S&P 500.

Valuation & Earnings

This table compares NeurAxis and Getinge AB (publ)”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeurAxis	$2.46 million	8.80	-$14.63 million	($1.84)	-1.68
Getinge AB (publ)	$3.00 billion	N/A	$227.45 million	$0.59	26.71

Getinge AB (publ) has higher revenue and earnings than NeurAxis. NeurAxis is trading at a lower price-to-earnings ratio than Getinge AB (publ), indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares NeurAxis and Getinge AB (publ)’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
NeurAxis	-492.76%	N/A	-641.25%
Getinge AB (publ)	5.04%	8.27%	4.60%

Insider and Institutional Ownership

11.8% of NeurAxis shares are owned by institutional investors. 15.2% of NeurAxis shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Getinge AB (publ) beats NeurAxis on 7 of the 10 factors compared between the two stocks.

About NeurAxis

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

About Getinge AB (publ)

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions. The company also provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, and drainage solutions; and operating room infrastructure equipment, anesthesia, advanced patient monitoring, operating room management, and operating room integration solutions. In addition, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices; bioreactor systems, DPTE systems, Getinge isolators, terminal sterilization products, and sterilizers; and vivarium, biohazardous materials handling solutions, labware cleaning and sterilization, upstream bioprocessing, and bioreactor preparation solutions. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.